Inducible secretion of large, biologically potent von Willebrand factor multimers
about
ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factorGMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodiesCytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathwayAssembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acidsThe unfolded von Willebrand factor response in bloodstream: the self-association perspectiveTerminal platelet production is regulated by von Willebrand factorDIDS prevents ischemic membrane degradation in cultured hippocampal neurons by inhibiting matrix metalloproteinase releaseThe von willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motifThrombin and vascular inflammationCleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditionsA Drosophila haemocyte-specific protein, hemolectin, similar to human von Willebrand factorTraumatic brain injury-associated coagulopathyCav3.1 (alpha1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells.Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing bloodSingle particle tracking of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type-1 repeats) molecules on endothelial von Willebrand factor stringsFurther characterization of ADAMTS-13 inactivation by thrombin.Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree.In vitro bleeding time test can diagnose thrombotic thrombocytopenia purpura and can possibly monitor therapeutic plasma apheresis.Systemic antithrombotic effects of ADAMTS13.Insights into von Willebrand factor proteolysis: clinical implications.Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay.The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis.Plasma exchange therapy for thrombotic microangiopathies.Endothelial cells and thrombotic microangiopathy.Deficiency of ADAMTS-13 in pediatric patients with severe sepsis and impact on in-hospital mortalitySevere Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibitionThrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury.Secretory pathways in endothelin synthesis.Visualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation.Force-induced cleavage of single VWFA1A2A3 tridomains by ADAMTS-13.Neuropeptide delivery to the brain: a von Willebrand factor signal peptide to direct neuropeptide secretion.Disulfide bond reduction of von Willebrand factor by ADAMTS-13.The emergence of the endothelial cell lineage in the chick embryo can be detected by uptake of acetylated low density lipoprotein and the presence of a von Willebrand-like factorMediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chainvon Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets.In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells.Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectinThe cDNA sequence of human endothelial cell multimerin. A unique protein with RGDS, coiled-coil, and epidermal growth factor-like domains and a carboxyl terminus similar to the globular domain of complement C1q and collagens type VIII and X.
P2860
Q24303587-19511C46-9730-4D9D-951E-A1FF835048B2Q24621927-086C7F41-9D47-4C99-8CA1-70C3E734419DQ24642212-0E403E3D-743C-4ECC-80A0-2C0861850062Q24644360-700463EC-7E16-4750-AF45-F95FECBB1371Q26852187-6AAFE1D5-6851-4184-86F9-4F71A44068BAQ27320100-B7FAFB0F-DAE8-4BDC-8E45-8DE1638854F1Q27321544-5BD98D56-B995-413F-B9CE-4500C8CE4DFBQ27744418-1C5BA8E0-DC90-4221-9009-51810DC4EB06Q28246124-7BE8371E-1EB5-45F6-B589-76D3EC0B34FEQ28267403-E9795108-3844-4E68-8672-8BDD03BEDEC7Q28355146-7870E357-7EA8-4623-886E-FA642355F087Q28391580-4BD8CBD2-78AB-436E-B902-49090127A02EQ28575971-B0E3C8A5-E88E-451B-92C0-46D5D63AF981Q28594414-CD85E4E3-0998-4262-9395-BA015473C0DEQ30479643-1DBCB671-BF0B-4776-989A-10F42EBF9E7FQ30575673-2C7EED34-6D95-436C-84D0-5E7074544D4EQ33278139-F909E49D-B1C7-4855-8205-104EBCC47D2EQ33284747-E8C35A8F-855A-4E48-9B56-CED888D459E6Q33333807-4645B565-4C7A-4A06-B116-95E311C10E63Q33370540-0FA37497-EA49-43CA-8ADC-B5B2BA735773Q33371131-98EC9D0B-CF53-4431-9758-56C9F80DC694Q33372567-8DAFAE23-9048-4485-88BE-189FD2B008DCQ33377815-C63DD437-273D-49C2-A340-C83877C5E0FDQ33393983-D3D98B31-08E9-49A3-892E-0B0445CBB5DDQ33401369-6F69B872-99B2-4468-9BFC-539057826825Q33406706-156058CF-43E6-41DF-903B-547A9165A1F2Q33419829-70F32A54-42D3-468B-8DFD-E524089C3AF9Q33426245-66C29713-52E3-4CB5-BBEE-B33D851738D0Q33541209-B335A1B6-81CE-4DC8-ACBB-10EDA9629C68Q33560436-BF713872-8969-4418-B862-E044EB1725EFQ33597546-A969284E-8D56-4184-BEE2-C5CA9E4025E9Q33654734-CD1EEABC-6FAC-42D4-8E11-43441346020AQ33718456-0B2F622A-504C-4FA9-8943-147D1013978BQ33842572-AB28596E-4C0C-425F-B23F-F146A6844EECQ33847858-FA2BCBFD-8D8A-4E4A-A463-60CE255AB31DQ33858605-4BF41D63-7122-407C-8665-9B7A77ED954FQ33873826-B2170C0F-EE15-4BDC-A013-1ED965E55322Q33910787-52F0BF28-1478-45FD-A90C-18C463046702Q34056920-62842D1E-E23E-4366-9A09-773E9EFC273CQ34301760-128365FF-3095-4F4D-94B4-4ED8855B23CC
P2860
Inducible secretion of large, biologically potent von Willebrand factor multimers
description
1986 nî lūn-bûn
@nan
1986 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Inducible secretion of large, biologically potent von Willebrand factor multimers
@ast
Inducible secretion of large, biologically potent von Willebrand factor multimers
@en
Inducible secretion of large, biologically potent von Willebrand factor multimers
@en-gb
Inducible secretion of large, biologically potent von Willebrand factor multimers
@nl
type
label
Inducible secretion of large, biologically potent von Willebrand factor multimers
@ast
Inducible secretion of large, biologically potent von Willebrand factor multimers
@en
Inducible secretion of large, biologically potent von Willebrand factor multimers
@en-gb
Inducible secretion of large, biologically potent von Willebrand factor multimers
@nl
prefLabel
Inducible secretion of large, biologically potent von Willebrand factor multimers
@ast
Inducible secretion of large, biologically potent von Willebrand factor multimers
@en
Inducible secretion of large, biologically potent von Willebrand factor multimers
@en-gb
Inducible secretion of large, biologically potent von Willebrand factor multimers
@nl
P2093
P1433
P1476
Inducible secretion of large, biologically potent von Willebrand factor multimers
@en
P2093
P304
P356
10.1016/0092-8674(86)90735-X
P407
P577
1986-07-18T00:00:00Z